000 | 01916 a2200541 4500 | ||
---|---|---|---|
005 | 20250517135703.0 | ||
264 | 0 | _c20170814 | |
008 | 201708s 0 0 eng d | ||
022 | _a1521-7035 | ||
024 | 7 |
_a10.1016/j.clim.2017.01.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPark, Chanho | |
245 | 0 | 0 |
_aPositive selection of type II collagen-reactive CD80 _h[electronic resource] |
260 |
_bClinical immunology (Orlando, Fla.) _c05 2017 |
||
300 |
_a64-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
650 | 0 | 4 | _aAgammaglobulinaemia Tyrosine Kinase |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArthritis, Experimental _ximmunology |
650 | 0 | 4 |
_aAutoimmunity _ximmunology |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aB7-1 Antigen _xmetabolism |
650 | 0 | 4 |
_aCell Survival _ximmunology |
650 | 0 | 4 |
_aCollagen Type II _ximmunology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aEnzyme-Linked Immunospot Assay |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Inbred DBA |
650 | 0 | 4 | _aPiperidines |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aSignaling Lymphocytic Activation Molecule Family _xmetabolism |
650 | 0 | 4 |
_aTransmembrane Activator and CAML Interactor Protein _xmetabolism |
700 | 1 | _aKho, In Seong | |
700 | 1 | _aIn Yang, Jeong | |
700 | 1 | _aKim, Min-Jung | |
700 | 1 | _aPark, Sunhoo | |
700 | 1 | _aCha, Hoon-Suk | |
700 | 1 | _aLee, Jaejoon | |
700 | 1 | _aKim, Tae Jin | |
773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 178 _gp. 64-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clim.2017.01.015 _zAvailable from publisher's website |
999 |
_c26851813 _d26851813 |